GGX1 - Global X China Biotech Innovation ETF (USD) (US37954Y2515)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

使用 Cbonds Watchlist 查找、保存和跟踪投资工具

有了 Cbonds Watchlist，您可以随时了解投资信息，做出明智决策！

Watchlist

需要访问

全选清除所有

保存关闭

ETF & Funds ceased circulation

(%)

US37954Y2515

GGX1 ISIN

交易所交易基金 (ETF)

基金类型

Mirae Asset Global Investments

提供商

每股资产净值

2020-09-22

成立日期

2 每年的次数

股息的支付

CEOJLS

CFI

代码

Closed

Status

Equity

投资项目

Biotech

部门

China

地区分布

Solactive China Biotech Innovation Index

基准

0.65 %

总成本比率

Physical

复制方法

1,41 百万 USD

基金资产总量 | 2024-02-15

1,41 百万 USD

股票类资产 | 2024-02-15

否

UCITS

价格动态的变化

Fund profile

The Global X China Biotech Innovation ETF aims to track the performance (before fees and expenses) of the Solactive China Biotech Innovation Index, which seeks to invest in companies that are directly involved in China’s biotechnology industry.

GGX1 profile

The Global X China Biotech Innovation ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in China. The Mirae Asset Global Investments fund’s base currency is USD and the share class was registered 22.09.2020 with unique ISIN - US37954Y2515. The total expense ratio is 0.65%. The Global X China Biotech Innovation ETF (USD) pays dividends 2 time(s) per year.

GGX1 - Global X China Biotech Innovation ETF (USD) (US37954Y2515)

使用 Cbonds Watchlist 查找、保存和跟踪投资工具

价格动态的变化

Fund profile

GGX1 profile

收入支付 (US37954Y2515)

其他 ETF 和基金提供商

相关 ETF 和基金